Compare ZURA & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | BCML |
|---|---|---|
| Founded | 2022 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 364.8M |
| IPO Year | 2021 | 2018 |
| Metric | ZURA | BCML |
|---|---|---|
| Price | $5.57 | $31.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $13.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 679.8K | 45.2K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.09% |
| EPS Growth | N/A | ★ 3.81 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | N/A | $5.25 |
| P/E Ratio | ★ N/A | $282.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $26.78 |
| 52 Week High | $7.25 | $34.98 |
| Indicator | ZURA | BCML |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 45.19 |
| Support Level | $5.62 | $27.80 |
| Resistance Level | $5.87 | $32.86 |
| Average True Range (ATR) | 0.31 | 0.78 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 53.13 | 75.79 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.